Continuous Glucose Monitoring Market Analysis from 2022 to 2034 Containing Market Size, Share along with its CAGR, Forecast and Trends

Top Countries — Revenue

USD Million/Billion
Loading…

Market Dynamics of Continuous Glucose Monitoring Market Analysis

↑ Growth Drivers

  • Increasing Incidence Of Diabetes Boost Market Growth
  • Healthcare Infrastructure Development Drives Market Growth
  • The Rising Demand for Continuously Tracking the Body's Glucose Levels Fueling the Market Growth

↓ Restraints

  • High Cost Related to Devices Will Limit Market Growth
  • Stringent regulatory scenario
  • Limiting Accessibility for Patients Without Comprehensive Health Insurance Coverage hamper the market

~ Trends

  • New product launches are a major factor driving the growth of the continuous glucose monitoring market
  • New Technology Development is helping to boost the continuous glucose monitoring market

Access the full forecast model.

Country-level data · Company profiles · Editable dataset · Analyst consultation included.

Continuous Glucose Monitoring Market Analysis — Presence

Interactive World Map

Click countries to explore
Loading map…

Regional and Country Analysis

  • North America — United States, Canada, Mexico
  • Europe — United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe
  • Asia Pacific — China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC
  • South America — Brazil, Argentina, Colombia, Peru, Chile, Rest of South America
  • Middle East — Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East
  • Africa — East Africa, West Africa, North Africa, South Africa

Region / Country 2021 (A)2025 (A)2033 (P) CAGR

A = Actual · E = Estimated · P = Projected · 🔒 Locked values require full access. Click headers to sort.

Unlock full regional dataset →

Segmentation Analysis

Market size by (Illustrative, 2025)
Share distribution (2025)

Charts are illustrative — exact values, country-level breakdowns, and full forecast in the paid report. Request a Free Sample PDF.

To learn more about market share and segmentation, request the free sample pages.

Competitive Landscape of the Continuous Glucose Monitoring Market

The Continuous glucose monitoring market is highly competitive, characterised by the presence of several global and regional players offering a wide range of products. Key companies in the market, such as Novo Nordisk A/S, Senseonics, DexCom, Inc., and Abbott Laboratories, dominate through their extensive product portfolios, strong distribution networks, and focus on innovation.

In November 2022, Senseonics Holdings, Inc., a leading medical technology company, announced a collaboration with the Nurse Practitioner Group (NPG). The collaboration aims to increase patient access by offering at-home and in-home insertion options for the Eversense E3 Continuous Glucose Monitoring System (CGM). Senseonics intends to expand the initiative into other key markets across the United States in the future. https://www.senseonics.com/investor-relations/news-releases/2022/11-03-2022-120329402 In December 2022, the US Food and Drug Administration (FDA) approved Dexcom's Continuous Glucose Monitoring System G7. Dexcom G7 is the most accurate integrated continuous glucose monitoring (iCGM) system, and its approval will help the company gain a strong foothold in the market. https://investors.dexcom.com/news/news-details/2022/Dexcom-G7-Receives-FDA-Clearance-The-Most-Accurate-Continuous-Glucose-Monitoring-System-Cleared-in-the-U.S/default.aspx In January 2024, Medtronic plc announced that its MiniMed 780G system with Simplera Sync had received CE Mark approval. Simple Sync is a technology that improves the user experience by simplifying the two-step insertion process. In addition, this new sensor is half the size of its predecessors. The MiniMed 780G system with Simplera Sync sensor is expected to launch in Europe via a limited release in the spring of 2024, followed by a phased commercial launch in the summer of the same year. https://news.medtronic.com/2024-01-08-Medtronic-Diabetes-announces-worlds-first-approval-for-MiniMed-TM-780G-System-with-Simplera-Sync-TM-disposable,-all-in-one-sensor

In October 2023, Dexcom, Inc. strengthened its footprint in Canada by introducing the Dexcom G7. In September 2023, Senseonics Holdings, Inc. completed the ENHANCE Pivotal Clinical Study. The study revealed that Eversense proved effective in facilitating sustainable diabetes management since it evidenced proper and secure monitoring for accurate and safe diabetes management.
(Source- https://investors.dexcom.com/news/news-details/2023/Dexcom-G7-Receives-Health-Canada-Approval-Next-Generation-Continuous-Glucose-Monitoring-System-With-Unmatched-Accuracy-Coming-to-Canadians/default.aspx)

Click any bar or cell to request the full company profile
Company2022 (A)2023 (A)2024 (A)2025 (A)
DexCom Inc.••• ••• ••• •••
Abbott••• ••• ••• •••
Medtronic••• ••• ••• •••
A. Menarini Diagnostics s.r.l••• ••• ••• •••
Novo Nordisk A/S••• ••• ••• •••
Senseonics••• ••• ••• •••
Johnson & Johnson Services Inc.••• ••• ••• •••
F. Hoffman-La Roche Ltd••• ••• ••• •••
Ypsomed AG••• ••• ••• •••
Murata Manufacturing Co. Ltd.••• ••• ••• •••
Medtrum Technologies Inc.••• ••• ••• •••
Others••• ••• ••• •••

Revenue data requires full access. *2nd & 3rd tier companies available on enquiry.

Request company profile for validation →

Report Scope & Analysis

According to Cognitive Market Research, the global Continuous glucose monitoring market size will be USD 4751.6 million in 2025. It will expand at a compound annual growth rate (CAGR) of 8.00% from 2025 to 2033.

  • North America held the major market share for more than 40% of the global revenue with a market size of USD 1758.09 million in 2025 and will grow at a compound annual growth rate (CAGR) of 7.0% from 2025 to 2033.
  • Europe accounted for a market share of over 30% of the global revenue with a market size of USD 1377.96 million.
  • APAC held a market share of around 23% of the global revenue with a market size of USD 1140.38 million in 2025 and will grow at a compound annual growth rate (CAGR) of 10.8% from 2025 to 2033.
  • South America has a market share of more than 5% of the global revenue with a market size of USD 180.56 million in 2025 and will grow at a compound annual growth rate (CAGR) of 8.7% from 2025 to 2033.
  • The Middle East had a market share of around 2% of the global revenue and was estimated at a market size of USD 190.06 million in 2025 and will grow at a compound annual growth rate (CAGR) of 9.3% from 2025 to 2033.
  • Africa had a market share of around 1% of the global revenue and was estimated at a market size of USD 104.54 million in 2025 and will grow at a compound annual growth rate (CAGR) of 8.3% from 2025 to 2033.
  • Dexcom G4 Platinum is the fastest growing category of the Continuous glucose monitoring industry

 

Introduction of the Continuous glucose monitoring Market

Continuous glucose monitoring systems (CGMs) are medical devices that detect and track glucose levels in real-time throughout the day and night. These systems typically include a small sensor inserted just beneath the skin that measures glucose levels every few minutes. This transmitter sends the data to a display device and a display device for interpreting the data. CGMs help people with diabetes and other conditions monitor their glucose levels and adjust their insulin or medication as needed. They can also detect patterns in glucose levels and alert users to potential problems earlier. The continuous glucose monitoring market benefits from growth and innovations in the medical device industry, which manufactures continuous glucose monitoring systems. The continuous glucose monitoring systems market is growing due to an increase in the number of companies developing continuous glucose monitoring systems

In September 2022, GlucoRx, a UK-based medical technology company, and Cardiff University announced the development of the world's first multi-sensor non-invasive continuous glucose monitoring system. It measures blood glucose levels every minute using radiofrequency technology and a multisensory approach that is both accurate and non-invasive. https://www.glucorx.co.uk/glucorx-announces-worlds-first-multi-sensor-non-invasive-glucose-monitoring/

Analyst Conclusion

Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.

The Continuous Glucose Monitoring Market Analysis is witnessing significant growth in the near future.

In 2023, the Transmitters segment accounted for a notable share of the Continuous Glucose Monitoring Market Analysis.

Supriya Yadav
Supriya Yadav Verified Analyst
Research Analyst at Cognitive Market Research · Cognitive Market Research
LinkedIn Profile Book Appointment

Frequently Asked Questions

The global market size for Continuous glucose monitoring in 2025 is USD 4751.6 million.
The global Continuous glucose monitoring market is expected to grow with a CAGR of 8.00% over the projected period.
North America held a significant global Continuous glucose monitoring market revenue share in 2025.
Asia-Pacific will witness the fastest growth of the global Continuous glucose monitoring market over the coming years.
The US had the most significant global Continuous glucose monitoring market revenue share in 2025.
The main drivers of the growth of the Continuous glucose monitoring market are the advancements in healthcare infrastructure, the growing prevalence of diabetes, and the heightened need for continuous monitoring of glucose levels in the body.
The Guardian Real Time CGM System dominates the Continuous Glucose Monitoring (CGM) market.

★ Reviews

Rate this report

Continuous Glucose Monitoring Market Analysis — Table of Contents

Disclaimer: Redacted sample for representative purposes. Charts and data do not depict actual statistics. TOC varies by license selection.
License Edition

Component Transmitters, Sensors, Receivers
Distribution Channel Retail Pharmacies, Online Pharmacies, Hospital Pharmacies
End Use Hospitals & Clinics, Home Healthcare, Ambulatory Surgical Centers (ASCs), Others
List of Competitors DexCom Inc., Abbott, Medtronic, A. Menarini Diagnostics s.r.l, Novo Nordisk A/S, Senseonics, Johnson & Johnson Services Inc., F. Hoffman-La Roche Ltd, Ypsomed AG, Murata Manufacturing Co. Ltd., Medtrum Technologies Inc., Others

Additional data which we are providing for Continuous Glucose Monitoring market

Supply Chain & Manufacturing Analysis
Patient & Clinician Adoption Trends
R&D Pipeline & Innovation
Technological Advancements
Pricing Trends & Analysis
Reimbursement & Insurance Coverage
Regulatory Landscape
 

  • 1.1 Global Power Realignment & Strategic Alliances
  • 1.2 Geopolitical Risk Landscape & Conflict Hotspots
  • 1.3 International Trade Relations & Market Access Environment
  • 1.4 Regulatory & Policy Shifts Impacting Cross-Border Operations
  • 1.5 Supply Chain Resilience, Localization & Resource Nationalism
  • 1.6 Technology Sovereignty & Digital Geopolitics
  • 1.7 Strategic Implications for Investment, Growth & Market Entry

  • 2.1 Competitive Landscape Disruption & Strategic Shifts
  • 2.2 AI-Driven Transformation of Industry Value Chain
  • 2.3 Evolution of Business Models & Revenue Streams
  • 2.4 Operational Efficiency & Cost Structure Transformation
  • 2.5 Product, Service & Innovation Acceleration
  • 2.6 Customer Behavior & Demand Evolution
  • 2.7 Future Outlook: AI-Led Market Evolution & Strategic Implications

  • 3.1 Global Continuous Glucose Monitoring Revenue Market Size, Trend Analysis 2022 - 2034
  • 3.2 Global Continuous Glucose Monitoring Volume Market Sales, Trend Analysis 2022 - 2034

  • Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.

    3.3 Global Continuous Glucose Monitoring Market Size By Regions 2022 - 2034
    • 3.3.1 Global Continuous Glucose Monitoring Revenue Market Size By Region
    • 3.3.2 Global Continuous Glucose Monitoring Volume Market Sales By Region
  • 3.4 Global Continuous Glucose Monitoring Market Size By Component 2022 - 2034
    • 3.4.1 Transmitters Market Size
    • 3.4.2 Sensors Market Size
    • 3.4.3 Receivers Market Size
  • 3.5 Global Continuous Glucose Monitoring Volume Market Sales By Component 2022 - 2034
    • 3.5.1 Transmitters Sales Volume
    • 3.5.2 Sensors Sales Volume
    • 3.5.3 Receivers Sales Volume
  • 3.6 Global Continuous Glucose Monitoring Market Size By Distribution Channel 2022 - 2034
    • 3.6.1 Retail Pharmacies Market Size
    • 3.6.2 Online Pharmacies Market Size
    • 3.6.3 Hospital Pharmacies Market Size
  • 3.7 Global Continuous Glucose Monitoring Volume Market Sales By Distribution Channel 2022 - 2034
    • 3.7.1 Retail Pharmacies Sales Volume
    • 3.7.2 Online Pharmacies Sales Volume
    • 3.7.3 Hospital Pharmacies Sales Volume
  • 3.8 Global Continuous Glucose Monitoring Market Size By End Use 2022 - 2034
    • 3.8.1 Hospitals & Clinics Market Size
    • 3.8.2 Home Healthcare Market Size
    • 3.8.3 Ambulatory Surgical Centers (ASCs) Market Size
    • 3.8.4 Others Market Size
  • 3.9 Global Continuous Glucose Monitoring Volume Market Sales By End Use 2022 - 2034
    • 3.9.1 Hospitals & Clinics Sales Volume
    • 3.9.2 Home Healthcare Sales Volume
    • 3.9.3 Ambulatory Surgical Centers (ASCs) Sales Volume
    • 3.9.4 Others Sales Volume
  • 3.10 Global Level Competitor Analysis (Subject to Data Availability (Private Players))

  • You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)

    3.11 Executive Summary Global Market (2021 vs 2025 vs 2033)
    • 3.11.1 Regional Market Revenue Summary 2021 vs 2025 vs 2033
    • 3.11.2 Regional Volume Market Summary 2021 vs 2025 vs 2033
    • 3.11.3 Global Market Revenue Split By Component
    • 3.11.4 Global Volume Market Split By Component
    • 3.11.5 Global Market Revenue Split By Distribution Channel
    • 3.11.6 Global Volume Market Split By Distribution Channel
    • 3.11.7 Global Market Revenue Split By End Use
    • 3.11.8 Global Volume Market Split By End Use

    • Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable

      3.11.9 Global Market Dynamics, Trends, Drivers, Restraints, Opportunities

  • 4.1 North America Continuous Glucose Monitoring Market Outlook
    • 4.1.1 North America Continuous Glucose Monitoring Market Size 2022 - 2034
    • 4.1.2 North America Continuous Glucose Monitoring Volume Market Sales 2022 - 2034
    • 4.1.3 North America Continuous Glucose Monitoring Market Size By Country 2022 - 2034
    • 4.1.4 North America Continuous Glucose Monitoring Volume Market Sales By Country 2022 - 2034
    • 4.1.5 North America Continuous Glucose Monitoring Market Size by Component 2022 - 2034
      • 4.1.5.1 North America Transmitters Market Size
      • 4.1.5.2 North America Sensors Market Size
      • 4.1.5.3 North America Receivers Market Size
    • 4.1.6 North America Continuous Glucose Monitoring Volume Market Sales by Component 2022 - 2034
      • 4.1.6.1 North America Transmitters Sales Volume
      • 4.1.6.2 North America Sensors Sales Volume
      • 4.1.6.3 North America Receivers Sales Volume
    • 4.1.7 North America Continuous Glucose Monitoring Market Size by Distribution Channel 2022 - 2034
      • 4.1.7.1 North America Retail Pharmacies Market Size
      • 4.1.7.2 North America Online Pharmacies Market Size
      • 4.1.7.3 North America Hospital Pharmacies Market Size
    • 4.1.8 North America Continuous Glucose Monitoring Volume Market Sales by Distribution Channel 2022 - 2034
      • 4.1.8.1 North America Retail Pharmacies Sales Volume
      • 4.1.8.2 North America Online Pharmacies Sales Volume
      • 4.1.8.3 North America Hospital Pharmacies Sales Volume
    • 4.1.9 North America Continuous Glucose Monitoring Market Size by End Use 2022 - 2034
      • 4.1.9.1 North America Hospitals & Clinics Market Size
      • 4.1.9.2 North America Home Healthcare Market Size
      • 4.1.9.3 North America Ambulatory Surgical Centers (ASCs) Market Size
      • 4.1.9.4 North America Others Market Size
    • 4.1.10 North America Continuous Glucose Monitoring Volume Market Sales by End Use 2022 - 2034
      • 4.1.10.1 North America Hospitals & Clinics Sales Volume
      • 4.1.10.2 North America Home Healthcare Sales Volume
      • 4.1.10.3 North America Ambulatory Surgical Centers (ASCs) Sales Volume
      • 4.1.10.4 North America Others Sales Volume

  • 5.1 Europe Continuous Glucose Monitoring Market Outlook
    • 5.1.1 Europe Continuous Glucose Monitoring Market Size 2022 - 2034
    • 5.1.2 Europe Continuous Glucose Monitoring Volume Market Sales 2022 - 2034
    • 5.1.3 Europe Continuous Glucose Monitoring Market Size By Country 2022 - 2034
    • 5.1.4 Europe Continuous Glucose Monitoring Volume Market Sales By Country 2022 - 2034
    • 5.1.5 Europe Continuous Glucose Monitoring Market Size by Component 2022 - 2034
      • 5.1.5.1 Europe Transmitters Market Size
      • 5.1.5.2 Europe Sensors Market Size
      • 5.1.5.3 Europe Receivers Market Size
    • 5.1.6 Europe Continuous Glucose Monitoring Volume Market Sales by Component 2022 - 2034
      • 5.1.6.1 Europe Transmitters Sales Volume
      • 5.1.6.2 Europe Sensors Sales Volume
      • 5.1.6.3 Europe Receivers Sales Volume
    • 5.1.7 Europe Continuous Glucose Monitoring Market Size by Distribution Channel 2022 - 2034
      • 5.1.7.1 Europe Retail Pharmacies Market Size
      • 5.1.7.2 Europe Online Pharmacies Market Size
      • 5.1.7.3 Europe Hospital Pharmacies Market Size
    • 5.1.8 Europe Continuous Glucose Monitoring Volume Market Sales by Distribution Channel 2022 - 2034
      • 5.1.8.1 Europe Retail Pharmacies Sales Volume
      • 5.1.8.2 Europe Online Pharmacies Sales Volume
      • 5.1.8.3 Europe Hospital Pharmacies Sales Volume
    • 5.1.9 Europe Continuous Glucose Monitoring Market Size by End Use 2022 - 2034
      • 5.1.9.1 Europe Hospitals & Clinics Market Size
      • 5.1.9.2 Europe Home Healthcare Market Size
      • 5.1.9.3 Europe Ambulatory Surgical Centers (ASCs) Market Size
      • 5.1.9.4 Europe Others Market Size
    • 5.1.10 Europe Continuous Glucose Monitoring Volume Market Sales by End Use 2022 - 2034
      • 5.1.10.1 Europe Hospitals & Clinics Sales Volume
      • 5.1.10.2 Europe Home Healthcare Sales Volume
      • 5.1.10.3 Europe Ambulatory Surgical Centers (ASCs) Sales Volume
      • 5.1.10.4 Europe Others Sales Volume

  • 6.1 Asia Pacific Continuous Glucose Monitoring Market Outlook
    • 6.1.1 Asia Pacific Continuous Glucose Monitoring Market Size 2022 - 2034
    • 6.1.2 Asia Pacific Continuous Glucose Monitoring Volume Market Sales 2022 - 2034
    • 6.1.3 Asia Pacific Continuous Glucose Monitoring Market Size By Country 2022 - 2034
    • 6.1.4 Asia Pacific Continuous Glucose Monitoring Volume Market Sales By Country 2022 - 2034
    • 6.1.5 Asia Pacific Continuous Glucose Monitoring Market Size by Component 2022 - 2034
      • 6.1.5.1 Asia Pacific Transmitters Market Size
      • 6.1.5.2 Asia Pacific Sensors Market Size
      • 6.1.5.3 Asia Pacific Receivers Market Size
    • 6.1.6 Asia Pacific Continuous Glucose Monitoring Volume Market Sales by Component 2022 - 2034
      • 6.1.6.1 Asia Pacific Transmitters Sales Volume
      • 6.1.6.2 Asia Pacific Sensors Sales Volume
      • 6.1.6.3 Asia Pacific Receivers Sales Volume
    • 6.1.7 Asia Pacific Continuous Glucose Monitoring Market Size by Distribution Channel 2022 - 2034
      • 6.1.7.1 Asia Pacific Retail Pharmacies Market Size
      • 6.1.7.2 Asia Pacific Online Pharmacies Market Size
      • 6.1.7.3 Asia Pacific Hospital Pharmacies Market Size
    • 6.1.8 Asia Pacific Continuous Glucose Monitoring Volume Market Sales by Distribution Channel 2022 - 2034
      • 6.1.8.1 Asia Pacific Retail Pharmacies Sales Volume
      • 6.1.8.2 Asia Pacific Online Pharmacies Sales Volume
      • 6.1.8.3 Asia Pacific Hospital Pharmacies Sales Volume
    • 6.1.9 Asia Pacific Continuous Glucose Monitoring Market Size by End Use 2022 - 2034
      • 6.1.9.1 Asia Pacific Hospitals & Clinics Market Size
      • 6.1.9.2 Asia Pacific Home Healthcare Market Size
      • 6.1.9.3 Asia Pacific Ambulatory Surgical Centers (ASCs) Market Size
      • 6.1.9.4 Asia Pacific Others Market Size
    • 6.1.10 Asia Pacific Continuous Glucose Monitoring Volume Market Sales by End Use 2022 - 2034
      • 6.1.10.1 Asia Pacific Hospitals & Clinics Sales Volume
      • 6.1.10.2 Asia Pacific Home Healthcare Sales Volume
      • 6.1.10.3 Asia Pacific Ambulatory Surgical Centers (ASCs) Sales Volume
      • 6.1.10.4 Asia Pacific Others Sales Volume

  • 7.1 South America Continuous Glucose Monitoring Market Outlook
    • 7.1.1 South America Continuous Glucose Monitoring Market Size 2022 - 2034
    • 7.1.2 South America Continuous Glucose Monitoring Volume Market Sales 2022 - 2034
    • 7.1.3 South America Continuous Glucose Monitoring Market Size By Country 2022 - 2034
    • 7.1.4 South America Continuous Glucose Monitoring Volume Market Sales By Country 2022 - 2034
    • 7.1.5 South America Continuous Glucose Monitoring Market Size by Component 2022 - 2034
      • 7.1.5.1 South America Transmitters Market Size
      • 7.1.5.2 South America Sensors Market Size
      • 7.1.5.3 South America Receivers Market Size
    • 7.1.6 South America Continuous Glucose Monitoring Volume Market Sales by Component 2022 - 2034
      • 7.1.6.1 South America Transmitters Sales Volume
      • 7.1.6.2 South America Sensors Sales Volume
      • 7.1.6.3 South America Receivers Sales Volume
    • 7.1.7 South America Continuous Glucose Monitoring Market Size by Distribution Channel 2022 - 2034
      • 7.1.7.1 South America Retail Pharmacies Market Size
      • 7.1.7.2 South America Online Pharmacies Market Size
      • 7.1.7.3 South America Hospital Pharmacies Market Size
    • 7.1.8 South America Continuous Glucose Monitoring Volume Market Sales by Distribution Channel 2022 - 2034
      • 7.1.8.1 South America Retail Pharmacies Sales Volume
      • 7.1.8.2 South America Online Pharmacies Sales Volume
      • 7.1.8.3 South America Hospital Pharmacies Sales Volume
    • 7.1.9 South America Continuous Glucose Monitoring Market Size by End Use 2022 - 2034
      • 7.1.9.1 South America Hospitals & Clinics Market Size
      • 7.1.9.2 South America Home Healthcare Market Size
      • 7.1.9.3 South America Ambulatory Surgical Centers (ASCs) Market Size
      • 7.1.9.4 South America Others Market Size
    • 7.1.10 South America Continuous Glucose Monitoring Volume Market Sales by End Use 2022 - 2034
      • 7.1.10.1 South America Hospitals & Clinics Sales Volume
      • 7.1.10.2 South America Home Healthcare Sales Volume
      • 7.1.10.3 South America Ambulatory Surgical Centers (ASCs) Sales Volume
      • 7.1.10.4 South America Others Sales Volume

  • 8.1 Middle East Continuous Glucose Monitoring Market Outlook
    • 8.1.1 Middle East Continuous Glucose Monitoring Market Size 2022 - 2034
    • 8.1.2 Middle East Continuous Glucose Monitoring Volume Market Sales 2022 - 2034
    • 8.1.3 Middle East Continuous Glucose Monitoring Market Size By Country 2022 - 2034
    • 8.1.4 Middle East Continuous Glucose Monitoring Volume Market Sales By Country 2022 - 2034
    • 8.1.5 Middle East Continuous Glucose Monitoring Market Size by Component 2022 - 2034
      • 8.1.5.1 Middle East Transmitters Market Size
      • 8.1.5.2 Middle East Sensors Market Size
      • 8.1.5.3 Middle East Receivers Market Size
    • 8.1.6 Middle East Continuous Glucose Monitoring Volume Market Sales by Component 2022 - 2034
      • 8.1.6.1 Middle East Transmitters Sales Volume
      • 8.1.6.2 Middle East Sensors Sales Volume
      • 8.1.6.3 Middle East Receivers Sales Volume
    • 8.1.7 Middle East Continuous Glucose Monitoring Market Size by Distribution Channel 2022 - 2034
      • 8.1.7.1 Middle East Retail Pharmacies Market Size
      • 8.1.7.2 Middle East Online Pharmacies Market Size
      • 8.1.7.3 Middle East Hospital Pharmacies Market Size
    • 8.1.8 Middle East Continuous Glucose Monitoring Volume Market Sales by Distribution Channel 2022 - 2034
      • 8.1.8.1 Middle East Retail Pharmacies Sales Volume
      • 8.1.8.2 Middle East Online Pharmacies Sales Volume
      • 8.1.8.3 Middle East Hospital Pharmacies Sales Volume
    • 8.1.9 Middle East Continuous Glucose Monitoring Market Size by End Use 2022 - 2034
      • 8.1.9.1 Middle East Hospitals & Clinics Market Size
      • 8.1.9.2 Middle East Home Healthcare Market Size
      • 8.1.9.3 Middle East Ambulatory Surgical Centers (ASCs) Market Size
      • 8.1.9.4 Middle East Others Market Size
    • 8.1.10 Middle East Continuous Glucose Monitoring Volume Market Sales by End Use 2022 - 2034
      • 8.1.10.1 Middle East Hospitals & Clinics Sales Volume
      • 8.1.10.2 Middle East Home Healthcare Sales Volume
      • 8.1.10.3 Middle East Ambulatory Surgical Centers (ASCs) Sales Volume
      • 8.1.10.4 Middle East Others Sales Volume

  • 9.1 Africa Continuous Glucose Monitoring Market Outlook
    • 9.1.1 Africa Continuous Glucose Monitoring Market Size 2022 - 2034
    • 9.1.2 Africa Continuous Glucose Monitoring Volume Market Sales 2022 - 2034
    • 9.1.3 Africa Continuous Glucose Monitoring Market Size By Country 2022 - 2034
    • 9.1.4 Africa Continuous Glucose Monitoring Volume Market Sales By Country 2022 - 2034
    • 9.1.5 Africa Continuous Glucose Monitoring Market Size by Component 2022 - 2034
      • 9.1.5.1 Africa Transmitters Market Size
      • 9.1.5.2 Africa Sensors Market Size
      • 9.1.5.3 Africa Receivers Market Size
    • 9.1.6 Africa Continuous Glucose Monitoring Volume Market Sales by Component 2022 - 2034
      • 9.1.6.1 Africa Transmitters Sales Volume
      • 9.1.6.2 Africa Sensors Sales Volume
      • 9.1.6.3 Africa Receivers Sales Volume
    • 9.1.7 Africa Continuous Glucose Monitoring Market Size by Distribution Channel 2022 - 2034
      • 9.1.7.1 Africa Retail Pharmacies Market Size
      • 9.1.7.2 Africa Online Pharmacies Market Size
      • 9.1.7.3 Africa Hospital Pharmacies Market Size
    • 9.1.8 Africa Continuous Glucose Monitoring Volume Market Sales by Distribution Channel 2022 - 2034
      • 9.1.8.1 Africa Retail Pharmacies Sales Volume
      • 9.1.8.2 Africa Online Pharmacies Sales Volume
      • 9.1.8.3 Africa Hospital Pharmacies Sales Volume
    • 9.1.9 Africa Continuous Glucose Monitoring Market Size by End Use 2022 - 2034
      • 9.1.9.1 Africa Hospitals & Clinics Market Size
      • 9.1.9.2 Africa Home Healthcare Market Size
      • 9.1.9.3 Africa Ambulatory Surgical Centers (ASCs) Market Size
      • 9.1.9.4 Africa Others Market Size
    • 9.1.10 Africa Continuous Glucose Monitoring Volume Market Sales by End Use 2022 - 2034
      • 9.1.10.1 Africa Hospitals & Clinics Sales Volume
      • 9.1.10.2 Africa Home Healthcare Sales Volume
      • 9.1.10.3 Africa Ambulatory Surgical Centers (ASCs) Sales Volume
      • 9.1.10.4 Africa Others Sales Volume

  • 10.1 Top Competitors Analysis

    • (Subject to Data Availability (Private Players))

      10.1.1 Global Continuous Glucose Monitoring Market Revenue and Share by Key Players
    • 10.1.2 Global Continuous Glucose Monitoring Market Volume and Share by Key Players
    • 10.1.3 Top Players Ranking 2024
    • 10.1.4 New Product Launch Analysis
    • 10.1.5 Industry Mergers and Acquisition Analysis
  • 10.2 Company Profile (Data Subject to Availability) Sample Format

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.1 DexCom Inc.
      • 10.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.1.2 Business Overview
      • 10.2.1.3 Financials (Subject to data availability)
      • 10.2.1.4 R&D Investment (Subject to data availability)
      • 10.2.1.5 Product Types Specification
      • 10.2.1.6 Business Strategy
      • 10.2.1.7 Recent Developments
      • 10.2.1.8 Management Change
      • 10.2.1.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.2 Abbott
      • 10.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.2.2 Business Overview
      • 10.2.2.3 Financials (Subject to data availability)
      • 10.2.2.4 R&D Investment (Subject to data availability)
      • 10.2.2.5 Product Types Specification
      • 10.2.2.6 Business Strategy
      • 10.2.2.7 Recent Developments
      • 10.2.2.8 Management Change
      • 10.2.2.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.3 Medtronic
      • 10.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.3.2 Business Overview
      • 10.2.3.3 Financials (Subject to data availability)
      • 10.2.3.4 R&D Investment (Subject to data availability)
      • 10.2.3.5 Product Types Specification
      • 10.2.3.6 Business Strategy
      • 10.2.3.7 Recent Developments
      • 10.2.3.8 Management Change
      • 10.2.3.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.4 A. Menarini Diagnostics s.r.l
      • 10.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.4.2 Business Overview
      • 10.2.4.3 Financials (Subject to data availability)
      • 10.2.4.4 R&D Investment (Subject to data availability)
      • 10.2.4.5 Product Types Specification
      • 10.2.4.6 Business Strategy
      • 10.2.4.7 Recent Developments
      • 10.2.4.8 Management Change
      • 10.2.4.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.5 Novo Nordisk A/S
      • 10.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.5.2 Business Overview
      • 10.2.5.3 Financials (Subject to data availability)
      • 10.2.5.4 R&D Investment (Subject to data availability)
      • 10.2.5.5 Product Types Specification
      • 10.2.5.6 Business Strategy
      • 10.2.5.7 Recent Developments
      • 10.2.5.8 Management Change
      • 10.2.5.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.6 Senseonics
      • 10.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.6.2 Business Overview
      • 10.2.6.3 Financials (Subject to data availability)
      • 10.2.6.4 R&D Investment (Subject to data availability)
      • 10.2.6.5 Product Types Specification
      • 10.2.6.6 Business Strategy
      • 10.2.6.7 Recent Developments
      • 10.2.6.8 Management Change
      • 10.2.6.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.7 Johnson & Johnson Services Inc.
      • 10.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.7.2 Business Overview
      • 10.2.7.3 Financials (Subject to data availability)
      • 10.2.7.4 R&D Investment (Subject to data availability)
      • 10.2.7.5 Product Types Specification
      • 10.2.7.6 Business Strategy
      • 10.2.7.7 Recent Developments
      • 10.2.7.8 Management Change
      • 10.2.7.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.8 F. Hoffman-La Roche Ltd
      • 10.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.8.2 Business Overview
      • 10.2.8.3 Financials (Subject to data availability)
      • 10.2.8.4 R&D Investment (Subject to data availability)
      • 10.2.8.5 Product Types Specification
      • 10.2.8.6 Business Strategy
      • 10.2.8.7 Recent Developments
      • 10.2.8.8 Management Change
      • 10.2.8.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.9 Ypsomed AG
      • 10.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.9.2 Business Overview
      • 10.2.9.3 Financials (Subject to data availability)
      • 10.2.9.4 R&D Investment (Subject to data availability)
      • 10.2.9.5 Product Types Specification
      • 10.2.9.6 Business Strategy
      • 10.2.9.7 Recent Developments
      • 10.2.9.8 Management Change
      • 10.2.9.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.10 Murata Manufacturing Co. Ltd.
      • 10.2.10.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.10.2 Business Overview
      • 10.2.10.3 Financials (Subject to data availability)
      • 10.2.10.4 R&D Investment (Subject to data availability)
      • 10.2.10.5 Product Types Specification
      • 10.2.10.6 Business Strategy
      • 10.2.10.7 Recent Developments
      • 10.2.10.8 Management Change
      • 10.2.10.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.11 Medtrum Technologies Inc.
      • 10.2.11.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.11.2 Business Overview
      • 10.2.11.3 Financials (Subject to data availability)
      • 10.2.11.4 R&D Investment (Subject to data availability)
      • 10.2.11.5 Product Types Specification
      • 10.2.11.6 Business Strategy
      • 10.2.11.7 Recent Developments
      • 10.2.11.8 Management Change
      • 10.2.11.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.12 Others
      • 10.2.12.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.12.2 Business Overview
      • 10.2.12.3 Financials (Subject to data availability)
      • 10.2.12.4 R&D Investment (Subject to data availability)
      • 10.2.12.5 Product Types Specification
      • 10.2.12.6 Business Strategy
      • 10.2.12.7 Recent Developments
      • 10.2.12.8 Management Change
      • 10.2.12.9 S.W.O.T Analysis

  • 11.1 Market Drivers
  • 11.2 Market Restraints
  • 11.3 Market Trends
  • 11.4 Market Opportunity
  • 11.5 Technological Road Map (Subject to Data Availability)
  • 11.6 Product Life Cycle (Subject to Data Availability)
  • 11.7 Customer and Buyer Behavior Analysis
    • 11.7.1 Consumer Demographics and Target Audience Assessment
    • 11.7.2 Consumer Purchase Behavior and Demand Assessment
    • 11.7.3 Consumer Pricing Dynamics and Affordability Assessment
    • 11.7.4 Digital Consumer Engagement and Online Adoption Analysis
    • 11.7.5 Future Consumption Trends and Demand Evolution Analysis
    • 11.7.6 Enterprise Procurement & Purchasing Behavior Analysis
    • 11.7.7 Buyer Decision-Making & Purchase Influence Assessment
    • 11.7.8 Customer Expectations & Service Experience Evaluation
    • 11.7.9 Vendor Selection & Supplier Preference Analysis
    • 11.7.10 Customer Retention & Loyalty Strategy Assessment
    • 11.7.11 Pricing Sensitivity & Value Perception Analysis
    • 11.7.12 Customer Segmentation & Demand Pattern Analysis
    • 11.7.13 Relationship Management & Strategic Partnership Trends
  • 11.8 Market Attractiveness Analysis
  • 11.9 PESTEL Analysis
    • 11.9.1 Political Factors
    • 11.9.2 Economic Factors
    • 11.9.3 Social Factors
    • 11.9.4 Technological Factors
    • 11.9.5 Legal Factors
    • 11.9.6 Environmental Factors
  • 11.10 Industrial Chain Analysis (Subject to Data Availability)
    • 11.10.1 Industry Chain Analysis
    • 11.10.2 Manufacturing Cost Analysis
    • 11.10.3 Supply Side Analysis
      • 11.10.3.1 Raw Material Analysis
      • 11.10.3.2 Raw Material Procurement Analysis
      • 11.10.3.3 Raw Material Price Trend Analysis
  • 11.11 Porter’s Five Forces Analysis
    • 11.11.1 Bargaining Power of Suppliers
    • 11.11.2 Bargaining Power of Buyers
    • 11.11.3 Threat of New Entrants
    • 11.11.4 Threat of Substitutes
    • 11.11.5 Degree of Competition
  • 11.12 Patent Analysis (Subject to Data Availability)
  • 11.13 ESG Analysis

  • 12.1 Transmitters
    • 12.1.1 Global Continuous Glucose Monitoring Revenue Market Size and Share by Transmitters 2022 - 2034
    • 12.1.2 Global Continuous Glucose Monitoring Volume Market Sales by Transmitters 2022 - 2034
  • 12.2 Sensors
    • 12.2.1 Global Continuous Glucose Monitoring Revenue Market Size and Share by Sensors 2022 - 2034
    • 12.2.2 Global Continuous Glucose Monitoring Volume Market Sales by Sensors 2022 - 2034
  • 12.3 Receivers
    • 12.3.1 Global Continuous Glucose Monitoring Revenue Market Size and Share by Receivers 2022 - 2034
    • 12.3.2 Global Continuous Glucose Monitoring Volume Market Sales by Receivers 2022 - 2034

  • 13.1 Retail Pharmacies
    • 13.1.1 Global Continuous Glucose Monitoring Revenue Market Size and Share by Retail Pharmacies 2022 - 2034
    • 13.1.2 Global Continuous Glucose Monitoring Volume Market Sales by Retail Pharmacies 2022 - 2034
  • 13.2 Online Pharmacies
    • 13.2.1 Global Continuous Glucose Monitoring Revenue Market Size and Share by Online Pharmacies 2022 - 2034
    • 13.2.2 Global Continuous Glucose Monitoring Volume Market Sales by Online Pharmacies 2022 - 2034
  • 13.3 Hospital Pharmacies
    • 13.3.1 Global Continuous Glucose Monitoring Revenue Market Size and Share by Hospital Pharmacies 2022 - 2034
    • 13.3.2 Global Continuous Glucose Monitoring Volume Market Sales by Hospital Pharmacies 2022 - 2034

  • 14.1 Hospitals & Clinics
    • 14.1.1 Global Continuous Glucose Monitoring Revenue Market Size and Share by Hospitals & Clinics 2022 - 2034
    • 14.1.2 Global Continuous Glucose Monitoring Volume Market Sales by Hospitals & Clinics 2022 - 2034
  • 14.2 Home Healthcare
    • 14.2.1 Global Continuous Glucose Monitoring Revenue Market Size and Share by Home Healthcare 2022 - 2034
    • 14.2.2 Global Continuous Glucose Monitoring Volume Market Sales by Home Healthcare 2022 - 2034
  • 14.3 Ambulatory Surgical Centers (ASCs)
    • 14.3.1 Global Continuous Glucose Monitoring Revenue Market Size and Share by Ambulatory Surgical Centers (ASCs) 2022 - 2034
    • 14.3.2 Global Continuous Glucose Monitoring Volume Market Sales by Ambulatory Surgical Centers (ASCs) 2022 - 2034
  • 14.4 Others
    • 14.4.1 Global Continuous Glucose Monitoring Revenue Market Size and Share by Others 2022 - 2034
    • 14.4.2 Global Continuous Glucose Monitoring Volume Market Sales by Others 2022 - 2034

  • 15.1 Company Gap Assessment Analysis
  • 15.2 Product & Service Portfolio Gap Analysis
  • 15.3 Demand-Supply Imbalance Analysis
  • 15.4 Market Opportunity & Unmet Needs Analysis
  • 15.5 Technology Adoption & Digital Transformation Gap Analysis
  • 15.6 Operational Efficiency & Process Gap Analysis
  • 15.7 Infrastructure & Capacity Gap Analysis
  • 15.8 Geographic Coverage & Distribution Gap Analysis
  • 15.9 Investment Opportunity & Funding Gap Analysis
  • 15.10 Pricing Structure & Margin Gap Analysis
  • 15.11 Innovation & R&D Capability Gap Analysis
  • 15.12 Policy, Compliance & Regulatory Gap Analysis
  • 15.13 Customer Experience & Expectation Gap Analysis
  • 15.14 Future Growth Opportunity Gap Analysis
  • 15.15 Market Accessibility & Penetration Gap Analysis

  • 16.1 Gross Margin Overview and Industry Profitability Trends
  • 16.2 Regional Gross Margin Performance Analysis
  • 16.3 Supply Chain and Distribution Impact on Gross Margins
  • 16.4 Pricing Strategy and Value-Added Margin Assessment
  • 16.5 Key Factors Influencing Gross Margin Variability
  • 16.6 Future Gross Margin Outlook and Profitability Trends

  • 17.1 Key Takeaways

  • Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.

    17.2 Analyst Point of View
  • 17.3 Assumptions and Acronyms

  • 18.1 Primary Data Collection
    • 18.1.1 Steps for Primary Data Collection
      • 18.1.1.1 Identification of KOL
    • 18.1.2 Backward Integration
    • 18.1.3 Forward Integration
    • 18.1.4 How Primary Research Help Us
    • 18.1.5 Modes of Primary Research
  • 18.2 Secondary Research
    • 18.2.1 How Secondary Research Help Us
    • 18.2.2 Sources of Secondary Research
  • 18.3 Data Validation
    • 18.3.1 Data Triangulation
    • 18.3.2 Top Down & Bottom Up Approach
    • 18.3.3 Cross check KOL Responses with Secondary Data
  • 18.4 Data Representation

Athenaeum AI Dashboard

Research Framework · 70:30 Primary:Secondary

Our Proprietary Methodology

Cognitive Market Research employs "The Full Truth™" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Supriya Yadav and team for the Continuous Glucose Monitoring Market Analysis Market analysis.

01

Primary Intelligence Gathering

Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.

02

Secondary Data Triangulation

Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.

03

Expert Validation Protocol

Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.

04

Athenaeum AI Processing

Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.

05

Editorial & QA Review

Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.

Data Assurance Metrics
Data Points Validated 10,400+
Expert Interviews 54
Countries Covered 39+
Company Profiles 12+
Forecast Accuracy (Historical) 94.2%
Report Pages 250+
Analytical Coverage
Market Sizing Revenue Forecast CAGR Analysis Competitor Benchmarking SWOT Porter's Analysis PESTEL Value Chain ESG Analysis Tariff Impact Patent Mapping Tech Trends

To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.

Latest News about Continuous Glucose Monitoring Market

Sources from Medical Devices & Consumables Industry

How We Serve You

Three Pillars of Market Intelligence

We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the Continuous Glucose Monitoring Market Analysis market.

Service 01

Market Survey

B2B B2C

Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the continuous glucose monitoring market analysis ecosystem — validated by our global panel of 10,000+ industrial respondents.

What's Included
  • Buyer intent & sentiment analysis
  • Purchase cycle mapping
  • Price sensitivity research
  • Channel preference profiling
  • Competitive perception study
Most Requested
Service 02

Customized Market Data & Reports

Custom Ready Report

Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.

What's Included
  • Ready syndicate report (250+ pages)
  • Custom data scope & segmentation
  • Excel quantitative models
  • Board-ready PPT with key findings
  • Secure cloud portal access
Service 03

Strategic Consultation

With Survey With Report

Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.

What's Included
  • Dedicated analyst assigned to you
  • Live walkthrough of findings
  • Strategic Q&A sessions
  • Go-to-market recommendations
  • NDA-protected engagement

Customize This Report

Tell us the specific segments, regions, or companies you need — and we will tailor the deliverable to your requirements.